Failure to Establish CAPA, MDR Procedures Land Warning for Simpro

The GMP Letter
A A
Failure to establish corrective and preventive action procedures as well as procedures for receiving and reviewing complaints landed Texas-based Simpro an FDA warning letter.

To View This Article:

Login

Subscribe To The GMP Letter